ÂÜÀòÂÒÂ×

The Leadership Team at Haystack Oncology drives the company’s strategic vision and operational excellence in advancing cutting-edge circulating tumor DNA detection technologies. Comprising key executives with expertise in innovation, finance, technology, and management, the team focuses on enhancing diagnostic capabilities for minimum residual disease and improving therapy decision-making to ultimately better patient outcomes in oncology.